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Abstract
Nucleotide-binding domain leucine rich repeat (NLR) proteins have emerged as fundamental
regulators of inflammation and immunity. Although first described eight years, a physiologic role
for NLRP12 has remained elusive until now. Here we describe a novel role for NLRs in
inflammation by regulating immune cell migration. We find that murine Nlrp12, an NLR linked to
atopic dermatitis and hereditary periodic fever in humans, is prominently expressed in dendritic
cells (DCs) and neutrophils. Nlrp12-deficient mice exhibit attenuated inflammatory responses in
two models of contact hypersensitivity that exhibit features of allergic dermatitis. This cannot be
attributed to defective antigen processing/presentation, inflammasome activation or measurable
changes in other inflammatory cytokines. Rather, Nlrp12−/− DCs display a significantly reduced
capacity to migrate to draining lymph nodes. Both DCs and neutrophils fail to respond to
chemokines in vitro. These findings indicate that NLRP12 is important in maintaining neutrophils
and peripheral DCs in a migration competent state.
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NLRs constitute a large family of mammalian genes that are homologous to innate immune
defense genes extending back to the plant kingdom. In animals, NLRs function as important
components of inflammation and immunity. To date, at least five NLR proteins are predicted
to form a large complex termed the inflammasome, which serves as a scaffold for caspase-1
activation and subsequent release of bioactive IL-1β and related cytokines. Other NLR
proteins such as NOD1, NOD2 and NLRX1 have been shown to function as regulators of
inflammatory cytokines, chemokines and antimicrobial peptides (1, 2); however, the in vivo
functions of the majority of NLR proteins remain to be elucidated.
We have previously shown that human NLRP12 is expressed by monocytes/macrophages
and granulocytes and inhibits the activation of noncanonical NF-κB by associating with and
inducing proteasome-mediated degradation of NF-κB inducing kinase (NIK) (3, 4). More
recently, mutations that result in a truncated form of NLRP12 are linked to hereditary
periodic fevers that manifest with recurrent fevers, joint pain, and skin urticaria (5). In
addition, a single nucleotide polymorphism in Intron 9 of NLRP12 is loosely associated with
atopic dermatitis (6). Here we present the first-identified in vivo role for NLRP12 by
demonstrating its role in the migration of DCs and neutrophils. This impacts contact
hypersensitivity (CHS), but cannot be attributed to impaired IL-1β production, and hence is
distinct from the inflammasome function.
Materials and Methods
Mice
Nlrp12−/− and Nlrp3−/− mice were generated by homologous recombination and backcrossed
for 9 generations to C57BL/6 (Jackson Laboratories) and maintained in specific pathogen-
free housing. OT-II mice, which express the OVA 323-339-specific TCR transgene on the
C57BL/6 background, were kindly provided by M. Croft (La Jolla Institute of Allergy and
Immunology). Experiments were performed with 6–12 week old age- and sex- matched
mice. All studies were conducted in accordance with the National Institutes of Health Guide
for the Care and Use of Laboratory Animals and the Institutional Animal Care and Use
Committee guidelines of UNC-CH.
Nlrp12−/− Genotyping
Genomic tail DNA was amplified with: F1 5’-CCCACAAAGTGATGTTGGACTG-3’, F2
5’-GCAGCGCATCGCCTTCTATC-3’, R1 5’-GAAGCAACCTCCGAATCAGAC-3’.
Expression analysis of Nlrp12
cDNA was synthesized from total RNA using moloney murine leukemia virus (MMLV)
reverse transcriptase (Invitrogen). Nlrp12 intron-spanning primers: F 5’-
GTCCAGACTCAGTCCACATA, R 5’-GTATAAGGCCAGCTCGATCA. GAPDH : F 5’-
TGAAGCAGGCATCTGAGGG, R 5’-CGAAGGTGGAAGAGTGGGAG. Cell populations
were isolated as described: T cells and B cells by negative selection; neutrophils from bone
marrow (BM) (7); DCs (8), macrophages (9), mast cells (10) and osteoclasts (11) from BM
precursors; Raw264.7 macrophages from American Type Culture Collection (ATCC);
Resident peritoneal macrophages by lavage with PBS and overnight adherence.
Generation of DCs and isolation of neutrophils
DCs were generated from BM precursors as described (8). Neutrophils were purified from
BM using a discontinuous Percoll (Sigma) gradient as described (7). Purity was 80–90% by
differential staining of cytospins and flow cytometry. Viability was >95%.
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Mice were sensitized by topical application of hapten to the footpads and depilated
abdomen: either 200µl of 3% oxazolone (Sigma-Aldrich) in ethanol, or 200µl of 0.5% FITC
(Sigma-Aldrich) in 1:1 acetone:dibutyl phthalate (Sigma-Aldrich). Five days later, 20µl of
1% oxazolone in ethanol or 20µl of 0.5% FITC in acetone:dibutyl phthalate was topically
applied to one ear. The opposite ear was mock-treated with solvent, and control mice were
treated with solvent on both ears. After 24 hours, mice were euthanized and 8mm circular
samples of ear tissue were excised and weighed, then the weight of the carrier-treated ear
was subtracted from that of the hapten-treated ear. Ear tissue was frozen on dry ice (see
below) or fixed in formalin, paraffin embedded, sectioned, and stained with H&E. Immune
cell infiltration was quantified as average pixel density (× 104) using ImageJ software from
4 fields per ear.
Ear tissue homogenates
Individual ears were manually homogenized in T-PER reagent (Thermo Scientific) using
RNase/DNase-free plastic pestles (Kontes) then sonicated. Total protein concentration was
determined by Bradford assay (Bio-Rad). IL-1β, TNFα, and MPO were measured by ELISA
(IL-1β and TNFα, BD Biosciences; MPO, Hycult Biotechnology).
FITC-induced in vivo migration (13)
Twenty µl of 0.5% FITC in 1:1 acetone:dibutyl phthalate was applied topically to both ears.
After 24 or 48 hours, draining (auricular and cervical) and non-draining lymph nodes (LNs)
were removed. Cells were stained with anti-CD11c-APC (HL3, BD Biosciences) and
analyzed by flow cytometry using a CyAn ADP flow cytometer (Beckman Coulter) and
FlowJo software (Tree Star Inc.). Ear epidermal sheets (14) were stained with biotin-labeled
anti-I-Ab (AF6-120.1; BD Biosciences), plus streptavidin-Alexa Fluor 595 (Invitrogen), then
visualized by fluorescent microscopy. DCs per 400× field are the mean of 4 fields per
sample, counted by a blinded reader.
Ova-induced in vivo migration (15)
Mice were injected s.c. into one foodpad with 20µl of Alexa Fluor 647 labeled Ova (2 mg/
ml in PBS; Invitrogen) emulsified in CFA. After 24 hours, draining (popliteal) and non-
draining LNs were removed and analyzed by flow cytometry as above.
In vitro migration
Bone marrow DCs (BMDC) were seeded at 2×105 per upper well of 96-well transwell plates
with 5µm pores (ChemoTx System; NeuroProbe), over chemokines (Peprotech) in serum-
free RPMI, and incubated at 37°C for 3 hours. Migrated cells were quantified using XTT
(Sigma). For neutrophil migration: 3µm pores, cultured 40 minutes at 37°C, migrated cells
quantified using ToxiLight Bioassay Kit (Lonza).
Statistics
Central tendencies are presented as mean ± SEM. Pairwise comparisons were made using
two-tailed tests, all α = 0.05: Mann Whitney U (in vivo Fig. 1B–E, 3B–D); Student’s t test
(in vitro Fig. 2F–G, 4I); Wilcoxon matched pairs (paired data Fig. 3E); One-sample
Wilcoxon signed-rank, hypothesized median = 100% (Fig. 3F). Outliers by Grubb’s test,
statistics computed with Prism 4 (GraphPad).
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Nlrp12−/− mice were generated by replacing a region of exon 3 containing the Walker A and
Walker B sequences with the neomycin resistance gene (Fig. 1A–B). Nlrp12−/− mice
displayed no gross abnormalities, and there were no identifiable abnormalities in the
cellularity of the peripheral blood, BM, spleen or LNs (Fig. S1). Similar to human NLRP12,
murine Nlrp12 was expressed in the BM and spleen, and at the cellular level in neutrophils
and DCs (Fig. 1C). Unlike human NLRP12, however, murine Nlrp12 was not highly
expressed in transformed Raw264.7 macrophages, macrophages differentiated from bone-
marrow precursors, or macrophages resident within the peritoneum.
NLRP12 is not required for IL-1β secretion in response to TLR +ATP stimulation
Given the critical role of other NLR proteins in IL-1β processing, we tested the ability of
Nlrp12−/− cells to produce IL-1β after stimulation with a variety of elicitors. No significant
difference in IL-1β production was detected in Nlrp12−/− vs. WT BM cells or BMDCs
stimulated with LPS, LPS + ATP, other TLR ligands, or TNFα (Fig. 1D). As a positive
control, Nlrp3−/− cells failed to produce IL-1β when properly stimulated (Fig 1D). Nlrp12
did not affect the production of IL-12p40, IL-6 and TNFα (Fig. S2), nor did it affect
survival or liver and kidney function in models of LPS-induced endotoxic shock (Figure
S3). Thus Nlrp12 in murine DCs did not significantly affect cytokine production in response
to TLR stimulation.
NLRP12 promotes hapten induced contact hypersensitivity
The importance of NLRP12 in cutaneous inflammation has been suggested through its
recent linkage to human hereditary periodic fevers with skin urticaria (5). We evaluated the
role of NLRP12 in cutaneous inflammation by assessing CHS, a mouse model of allergic
dermatitis. WT and Nlrp12−/− mice were sensitized topically on the abdomen with hapten –
either oxazolone or FITC and elicited 5 days later on the ear. Compared to controls,
Nlrp12−/− mice displayed a weaker response to both haptens, as indicated by significantly
reduced swelling (Fig. 2A–C) and reduced cellular accumulation at the site of elicitation
(Fig. 2D). The partial effect of Nlrp12 deletion is typical of other NLR responses in mice
(16). During a CHS response, neutrophils migrate out of the bloodstream and into the
affected skin tissue (17). In Nlrp12−/− mice, the accumulation of myeloperoxidase-positive
(MPO) neutrophils in the skin was significantly reduced in hapten-treated ears compared to
WT mice (Fig 2E).
Others have shown that CHS is attenuated in Nlrp3−/− mice due to decreased IL-1β (18). Ear
tissues from Nlrp12−/− mice did not show reduced IL-1β (Fig. 2F) nor reduced TNFα (Fig.
2G). These data suggest that Nlrp12 does not affect inflammasome function nor TNFα in
CHS.
NLRP12 potentiates DC migration from the periphery to the draining lymph nodes
Given the critical role of DCs in the CHS model (19) coupled with the high expression of
Nlrp12 in these cells, we determined if DC function is dependent upon NLRP12. Expression
of MHC class II and co-stimulatory factors CD80, CD86 and CD40 was not affected by
Nlrp12 during BMDC maturation (Fig S4). To determine if Nlrp12 affected antigen
processing and presentation, WT and Nlrp12−/− BMDCs were pulsed with OVA and then
co-cultured with CFSE-labeled OT-II splenocytes specific for the OVA peptide 323–339.
WT and Nlrp12−/− BMDCs induced equivalent antigen-dependent T cell proliferation,
indicating that NLRP12 was not required for antigen presentation by DCs (Fig. S5).
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A key function of DCs in the CHS model is to collect peripheral antigens and migrate to
draining LNs. To evaluate DC migration in vivo, FITC was applied topically to the ears of
WT and Nlrp12−/− mice. Draining LNs were removed 24 and 48 hours later, and the
presence of FITC+ CD11c+ DCs was assessed by flow cytometry. FITC+ DCs in the
draining LNs of Nlrp12−/− mice were significantly reduced compared to WT mice 24 and 48
hours after FITC application (Fig. 3A–C). These DCs did not traffic to other immune
organs, as FITC+ CD11c+ DCs were not detected in non-draining LNs, BM or spleen (Fig.
3A and S6). In contrast, Nlrp3−/− DC migration to draining LNs was comparable to WT
DCs (Fig. 3D). Quantification of DCs in untreated skin revealed that Nlrp12 did not affect
resting DC numbers (Fig. 3E). However, following FITC treatment the number of WT skin
DCs decreased by over 40% while the number of Nlrp12−/− skin DCs changed by less than
10%, indicating that Nlrp12 is required for DCs egress from the skin (Fig. 3E).
To further examine the migratory capacity of Nlrp12−/− DCs, we measured migration of
DCs to the draining LNs in response to s.c. OVA antigen. The absence of Nlrp12 reduced
OVA+ DCs in the draining LNs by nearly 75% (Fig. 3F). These results support migratory
defects in Nlrp12−/− DCs.
Nlrp12−/− DCs and neutrophils fail to respond to chemokines in vitro
DCs migrate to draining LNs in response to chemokine engagement of CCR7 and CXCR4
on DCs (20, 21). Nlrp12 did not affect the expression of CCR7 and CXCR4 on BMDCs
(table S1). However Nlrp12−/− BMDCs demonstrated significantly reduced migration
toward CCR7 and CXCR4 ligands CCL19, CCL21, and CXCL12 in an in vitro transwell
assay (Fig. 4A–C and table S2). In contrast, Nlrp3−/− BMDCs exhibited normal migration
toward these chemokines (Fig. 4D–F). As a negative control, BMDC from all genotypes
failed to migrate toward CCL5 (Fig. 4G–H), a chemokine for immature DCs (22). The
migration of Nlrp12−/− neutrophils to the neutrophil attracting chemokine CXCL1 was also
reduced by approximately 50% when compared to WT neutrophils (Fig. 4I).
NLR proteins intersect various pathways that are integral to inflammation and immunity (1).
Based upon our previous observation of inappropriate noncanonical NF-κB activation in
human monocytic cell lines with reduced NLRP12, we predicted a pro-inflammatory
phenotype for Nlrp12-deficient mice. Surprisingly, pro-inflammatory cytokine production
was unaffected by the absence of NLRP12, and the CHS response mounted in these mice
was significantly attenuated relative to WT mice. Nlrp12 did not affect BMDC maturation
nor antigen presenting functions in vitro. Instead, Nlrp12 affected DC migration from the
periphery to the draining LNs during CHS and subcutaneous immunization and migration to
LN homing chemokines. Nlrp12 also affected neutrophil response to chemotactic stimuli,
indicating a central role for NLRP12 in licensing cellular migration. Hereditary periodic
fever is associated with two mutations in human NLRP12 (5), and it is tantalizing to
speculate that altered neutrophil migration or retention of activated DCs in the periphery
may lead to the recurring cutaneous inflammation experienced by these patients.
We did not find an in vivo effect of NLRP12 on pro-inflammatory cytokine production. In
contrast to these results, a previous study showed that silencing of NLRP12 with small
hairpin (sh) RNA leads to increased production of IL-6 and TNFα in human cells of
monocytic lineage (4). This implies that NLRP12 may exhibit distinct functions in DCs and
monocytes/macrophages; however, since mouse macrophages do not express detectable
Nlrp12, its deletion is not predicted to affect macrophage function in mice. We also were
unable to find an effect of Nlrp12 deletion on IL-1β production, which is a well-established
role for other NLRs. Human NLRP12 can co-localize with inflammasome components and
promote IL-1β secretion when overexpressed (23). It is possible that the proper agonist/
ligand, once identified, can activate NLRP12 inflammasome function. In agreement with
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previous studies from our group and others (4, 24), we found that NLRP12 was not required
for IL-1β secretion in response to TNFα or TLR ligands +/− ATP.
In summary we reveal a novel regulatory role for NLRP12 in licensing cellular migration
that affected a DC-dependent model of cutaneous inflammation. Unlike Nlrp3−/− mice, this
is not correlated with a defect in inflammasome activation and IL-1β production.
Considering that NLRs appear to cluster by their functional properties, it is likely that other
NLRs will be found to similarly affect physiological processes by controlling cellular
migration.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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(A) Targeted disruption of the Nlrp12 gene. (B) PCR genotyping from Nlrp12+/− crosses.
(C) Expression analysis of Nlrp12 by RT-PCR. BMD, bone marrow derived; iDC, immature
DCs before maturation stimulus; mDC, DCs after TNFα maturation; mac, macrophage. (D)
IL-1β production from BMDC. No tx, no treatment; pIC, polyinosine-polycytidylic acid;
pLPS, phenol purified LPS; cLPS, commercial LPS.
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Nlrp12−/− mice fail to mount a robust CHS response. (A–C) CHS-induced ear swelling in
response to oxazalone (A–B, WT n=12, Nlrp12−/− n=13, Ctrl n=6) and FITC (C), WT n=7,
Nlrp12−/− n=8, Ctrl n=3). (D) Cellularity of CHS ear tissue (WT n=8, Nlrp12−/− n=7). (E)
Quantification of MPO+ neutrophils in CHS ear tissue (WT n=8, Nlrp12−/− n=8). (F) IL-1β
and (G) TNFα in CHS ear tissue (WT n=5, Nlrp12−/− n=5). All experiments were repeated
2–3 times, all data are presented as mean ± SEM. * P<0.05, ** P<0.01.
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DC migration to draining LNs is significantly impaired in Nlrp12−/− mice (A–C) FITC+
CD11c+ cells in the draining LN 24 h (A–B) and 48 h (C) after topical application of FITC
(WT n=5, Nlrp12−/− n=5). (D) FITC+ CD11c+ cells in the draining LN of WT (n=5) and
Nlrp3−/− (n=5) DCs 24 h after topical application of FITC. (E) Quantification of I-Ab+ skin
DCs in ear epidermal sheets, untreated (Untx) or FITC-treated (FITC) for 24 h (WT n=4,
Nlrp12−/− n=5). (F) Ova+ I-Ab+ CD11c+ cells in the draining LN 24 h following s.c.
injection of fluorescent Ova in CFA. Nlrp12−/− values were normalized to WT values set at
100% (WT n=6, Nlrp12−/− n=5). All experiments were repeated 2–3 times, all data are
presented as mean ± SEM. * P<0.05, ** P<0.01.
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Deletion of Nlrp12 impairs cell migration in vitro. Migration of (A–C, G) WT (○) and
Nlrp12−/− (◆) BMDCs, and of (D–F, H) WT (○) and Nlrp3−/− ( ) BMDCs to the indicated
chemokine. Data are representative of 3–5 experiments and are presented as mean ± SEM of
one experiment. Data from all experiments with associated pairwise comparison statistics
are presented in table S4. (I) Migration of WT and Nlrp12−/− neutrophils to CXCL1. Data
are comprised of three independent experiments, presented as mean ± SEM, and pairwise
comparisons were made using two-tailed Student’s t test, α = 0.05. * P<0.05.
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